[
  {
    "ts": "2026-01-02T09:55:45+00:00",
    "headline": "What to Expect From AbbVie's Next Quarterly Earnings Report",
    "summary": "AbbVie will release its fourth-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.",
    "url": "https://www.barchart.com/story/news/36857782/what-to-expect-from-abbvie-s-next-quarterly-earnings-report",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "1a633c73-3ac3-318a-8610-f5616c96bb22",
      "content": {
        "id": "1a633c73-3ac3-318a-8610-f5616c96bb22",
        "contentType": "STORY",
        "title": "What to Expect From AbbVie's Next Quarterly Earnings Report",
        "description": "",
        "summary": "AbbVie will release its fourth-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.",
        "pubDate": "2026-01-02T09:55:45Z",
        "displayTime": "2026-01-02T09:55:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Abbvie Inc logo and meds- by Ascannio via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sV5dyhX8uDCJGzeCE4rkkw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6yl69TRTYNaI9jQOQ7CDCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36857782/what-to-expect-from-abbvie-s-next-quarterly-earnings-report",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-abbvies-next-quarterly-earnings-095545192.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T12:44:00+00:00",
    "headline": "Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth",
    "summary": "ABBV's neuroscience franchise now drives more than 17% of revenues, with strong Botox, Vraylar and migraine drug sales fueling double-digit growth.",
    "url": "https://finance.yahoo.com/news/heres-abbvies-neuroscience-portfolio-aiding-124400302.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2a65e28b-177a-31e6-97a1-3357440a62c2",
      "content": {
        "id": "2a65e28b-177a-31e6-97a1-3357440a62c2",
        "contentType": "STORY",
        "title": "Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth",
        "description": "",
        "summary": "ABBV's neuroscience franchise now drives more than 17% of revenues, with strong Botox, Vraylar and migraine drug sales fueling double-digit growth.",
        "pubDate": "2026-01-02T12:44:00Z",
        "displayTime": "2026-01-02T12:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-abbvies-neuroscience-portfolio-aiding-124400302.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-abbvies-neuroscience-portfolio-aiding-124400302.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:27:49+00:00",
    "headline": "Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug",
    "summary": "Ironwood Pharmaceuticals (IRWD) shares jumped early Friday after the biotechnology company said it e",
    "url": "https://finance.yahoo.com/news/ironwood-pharmaceuticals-projects-higher-2026-142749736.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "d4dff0c1-b137-32d2-aa95-496ceca91a4f",
      "content": {
        "id": "d4dff0c1-b137-32d2-aa95-496ceca91a4f",
        "contentType": "STORY",
        "title": "Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug",
        "description": "",
        "summary": "Ironwood Pharmaceuticals (IRWD) shares jumped early Friday after the biotechnology company said it e",
        "pubDate": "2026-01-02T14:27:49Z",
        "displayTime": "2026-01-02T14:27:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/43f5a8d46d469713393152466937786b",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "IRWD, Ironwood.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rZgbXrdQRKRGBn4VHEO1Rg--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/43f5a8d46d469713393152466937786b.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/akAa6_SENnjl.qApmw74Ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/43f5a8d46d469713393152466937786b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ironwood-pharmaceuticals-projects-higher-2026-142749736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ironwood-pharmaceuticals-projects-higher-2026-142749736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IRWD"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:53:00+00:00",
    "headline": "Will ANIP's Rare Disease Franchise Maintain Momentum in 2026?",
    "summary": "ANIP's rare disease push, led by Cortrophin Gel, drove 70% sales growth in the first nine months of 2025, lifting revenue outlook.",
    "url": "https://finance.yahoo.com/news/anips-rare-disease-franchise-maintain-145300002.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a699462c-6a4e-3cdf-9312-b2b0b2ce66bd",
      "content": {
        "id": "a699462c-6a4e-3cdf-9312-b2b0b2ce66bd",
        "contentType": "STORY",
        "title": "Will ANIP's Rare Disease Franchise Maintain Momentum in 2026?",
        "description": "",
        "summary": "ANIP's rare disease push, led by Cortrophin Gel, drove 70% sales growth in the first nine months of 2025, lifting revenue outlook.",
        "pubDate": "2026-01-02T14:53:00Z",
        "displayTime": "2026-01-02T14:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d7sHwZPFV1U3B4BGoNlXfg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k5CBlnqEqKxZI1S0BuG_ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/anips-rare-disease-franchise-maintain-145300002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/anips-rare-disease-franchise-maintain-145300002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ANIP"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:51:00+00:00",
    "headline": "Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China",
    "summary": "Novo Nordisk cuts Wegovy prices in China, which may shift investor focus toward diversified healthcare ETFs.",
    "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bb9f3282-49ac-31b5-a467-31f9dc7f4c90",
      "content": {
        "id": "bb9f3282-49ac-31b5-a467-31f9dc7f4c90",
        "contentType": "STORY",
        "title": "Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China",
        "description": "",
        "summary": "Novo Nordisk cuts Wegovy prices in China, which may shift investor focus toward diversified healthcare ETFs.",
        "pubDate": "2026-01-02T14:51:00Z",
        "displayTime": "2026-01-02T14:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3GkkLZFYbl52wnpptRqd1w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7SzRmhAvDPGiiSvT8MWFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "IYH"
            },
            {
              "symbol": "IXJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]